Money.ca on MSN
I nearly wasted my first $2,000 — here’s what every Canadian newbie investor needs to know
I know, I know: Yawn! Investing $2,000 in stocks isn’t as fun as flying to the Caribbean — but hear me out: If you start investing early, you could set up a powerful habit that will save your future ...
TORONTO, Sept. 29, 2025 /PRNewswire/ -- A new survey commissioned by CIBC Investor's Edge finds a generational shift in investing behaviour: nearly half of Gen Z and Millennial investors (45 per cent) ...
Survey shows personality and emotion are shaping investing decisions, particularly among Gen Z and Millennials TORONTO, Sept. 29, 2025 /CNW/ -- A new survey commissioned by CIBC Investor's Edge finds ...
Have you held units of a CIBC mutual fund or a Renaissance mutual fund (other than through a discount broker)? TORONTO, Sept. 26, 2025 /CNW/ - A class action settlement has been reached with Canadian ...
Money.ca on MSN
Young Canadians investing on instinct as emotions drive market decisions, CIBC poll finds
Despite the unease, Canadians aren’t giving up on markets. Nearly one-third (31%) of those surveyed said they feel hopeful about investing, and many younger Canadians report seeing investing as a way ...
MONTRÉAL, Sept. 23, 2025 /PRNewswire/ - Curtis Millen, EVP and Chief Financial Officer of BCE Inc. (TSX: BCE) (NYSE: BCE) will participate in a fireside chat at the 24th Annual CIBC Eastern ...
New Delhi, Sep 27 (PTI) Naukri.com-parent Info Edge, whose long-term bets on Indian startups ranging from Zomato to Policybazaar yielded blockbuster returns, has been named the country's most ...
Naukri.com-parent Info Edge, whose long-term bets on Indian start-ups ranging from Zomato to Policybazaar yielded blockbuster returns, has been named the country's most successful venture investor, ...
Naukri.com-parent Info Edge, whose long-term bets on Indian startups ranging from Zomato to Policybazaar yielded blockbuster returns, has been named the country's most successful venture investor, ...
A mood of uncertainty hangs over India’s pharmaceutical sector as US President Donald Trump’s latest tariff threats have unsettled investors and policymakers alike. But behind closed doors, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results